Hospital News and Research

RSS

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that it has entered into an exclusive, world-wide licensing agreement with Syntiron to develop and commercialize its prophylactic vaccine against Staphylococcus, including Methicillin-Resistant Staphylococcus aureus or MRSA.

17 Dec 2009

Flowers can uplift patients’ mood and reduce pain and anxiety

Does flower water harbour potentially deadly bacteria? Do bedside blooms compete with patients for oxygen? Do bouquets pose a health and safety risk around medical equipment?

17 Dec 2009

Hospitals increase charity care with customized scoring solution

Medlytix, a national healthcare consulting firm, reported success this week in reaching a key half-billion dollar milestone - the total amount of money that its hospital clients have provided in financial assistance to more than a half-million patients nationwide by doing a better job of properly classifying charity care - in less than two years.

17 Dec 2009

$15 million federal funds for new cancer research program

As a result of C3: Colorectal Cancer Coalition's advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill.

17 Dec 2009

Group of drugs used to treat heart failure shows promise for fighting colon cancer

Scientists in Sweden are reporting for the first time that a group of drugs used to treat heart failure shows promise for fighting colon cancer. The study is in ACS' Journal of Natural Products, a monthly publication. Colon cancer is the third most common cancer in the United States, with more than 150,000 cases diagnosed in the U.S. each year.

17 Dec 2009

UC San Diego Medical Center performs complex surgery on brain lesion

Over three decades, a world-recognized medical team at UC San Diego Medical Center has spurred the evolution of a complex surgery to destroy dangerous clusters of arteries and veins in the brain. Integrating innovative approaches in radiology, anesthesia, and surgery, the team has perfected a method to systematically starve these abnormal brain lesions, artery by artery, vein by vein.

17 Dec 2009

HHS Secretary Kathleen Sebelius announces $27 million to help older individuals with chronic conditions

HHS Secretary Kathleen Sebelius has announced the availability of $27 million to help older individuals with chronic conditions to improve their health and reduce their use of costly medical care.

17 Dec 2009

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.

16 Dec 2009

Medical device makers divided over reduced tax

Medical device makers are still split over a reduced tax in the Senate health bill, Roll Call reports.

16 Dec 2009

Hospital, physician lobbyists fought Medicare buy-in proposal

The Washington Post offers a look at how hospital and physician lobbyists adamantly fought the Medicare buy-in proposal, which would have allowed people age 55 to 64 to buy Medicare coverage. Such efforts led to the proposal's disappearance within six days.

16 Dec 2009

Nanotherapeutics acquires Ramoplanin clinical program from Oscient Pharmaceuticals

Nanotherapeutics, Inc., a privately held biopharmaceutical company, announced that it has acquired in bankruptcy proceedings two late stage clinical programs: Ramoplanin from Oscient Pharmaceuticals Corporation and PRX-3140 from EPIX Pharmaceuticals, Inc.

16 Dec 2009

Mission Health System to implement RIVA

Mission Health System in Asheville, North Carolina has ordered a RIVA System (Robotic Intravenous Automation) - a self-contained unit for filling IV syringes and bags - from Intelligent Hospital Systems (IH Systems). The Mission Health System, which includes the Memorial and St. Joseph's campuses, will be using the RIVA System on their off-site pharmacy for both centers.

16 Dec 2009

Immigrants lose lawsuit against hospital in Atlanta

"Efforts to force the public hospital [in Atlanta, Ga.] to continue providing free dialysis treatment to a group of immigrants, most of them illegal, suffered a setback on Tuesday when a judge dismissed a lawsuit challenging the recent closing of the hospital's outpatient renal clinic," The New York Times reports.

16 Dec 2009

EMD Serono, Brigham and Women's Hospital collaborate in MS research

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced a strategic collaboration with Brigham and Women's Hospital in Boston, to advance basic and clinical research in multiple sclerosis (MS), with the goal of generating new and innovative discoveries that advance treatment for people living with this condition. The multi-faceted agreement will run for up to 5 years, with the potential to renew the alliance thereafter. Both parties decided not to disclose financial details.

16 Dec 2009

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

During the 5th International Congress of Corneal Cross Linking for Keratoconus in Leipzig, Germany on December 5th, Avedro presented encouraging early clinical results for treating keratoconus, a progressive disease of the cornea of the eye. The procedure, known as Keraflex® KXL, is non-incisional and reshapes the cornea without removing any tissue.

16 Dec 2009

Cost-effective alternative to original Medicare or Medicare supplement plan for Syracuse-area residents

At a time when many people with Medicare in Syracuse are increasingly concerned about finding affordable health insurance, they now have a new Medicare Advantage option for 2010.

16 Dec 2009

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.

16 Dec 2009

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

State government leaders, Medicaid agencies, hospital and physician associations, and other entities are formulating strategies for tapping federal stimulus money to create interoperable health information exchanges (HIEs).

16 Dec 2009

MDPathways and RNPathways launched to tackle healthcare recruitment and staffing issues

Imagine what it would be like if every physician and nurse took today off…virtual chaos. More than any other industry in the world, people are the most vital resource in healthcare. Pathways, LLC. has solved a complex healthcare recruiting and staffing problem by connecting physicians and nurses to authentic career opportunities.

16 Dec 2009

First Edition: December 16, 2009

Kaiser Health News staff writer Mary Agnes Carey explores some of the key issues within current health reform proposals related to Medicare and cost. "In an effort to rein in health costs, Senate Democrats are proposing steps that would give federal agencies more power to overhaul how Medicare pays for medical care - and thus reduce Congress' own role in running the giant program for the elderly" (Kaiser Health News).

16 Dec 2009

Hospital News and Research

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

Flowers can uplift patients’ mood and reduce pain and anxiety

Hospitals increase charity care with customized scoring solution

$15 million federal funds for new cancer research program

Group of drugs used to treat heart failure shows promise for fighting colon cancer

UC San Diego Medical Center performs complex surgery on brain lesion

HHS Secretary Kathleen Sebelius announces $27 million to help older individuals with chronic conditions

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Medical device makers divided over reduced tax

Hospital, physician lobbyists fought Medicare buy-in proposal

Nanotherapeutics acquires Ramoplanin clinical program from Oscient Pharmaceuticals

Mission Health System to implement RIVA

Immigrants lose lawsuit against hospital in Atlanta

EMD Serono, Brigham and Women's Hospital collaborate in MS research

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

Cost-effective alternative to original Medicare or Medicare supplement plan for Syracuse-area residents

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

MDPathways and RNPathways launched to tackle healthcare recruitment and staffing issues

First Edition: December 16, 2009

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News